Reaction

Stoma Site Hypergranulation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 624 reports · 13 co-occurring drugs

As of the last recalculation, Stoma Site Hypergranulation appears in 624 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is ROTIGOTINE (PRR 122.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Rotigotine49122.6123.0
Carbidopa And Levodopa128113.0113.3
Rasagiline Mesylate3094.494.6
Rivastigmine3871.671.7
Amantadine2863.263.3
Pramipexole2249.649.7
Ropinirole1738.038.0
Levodopa1233.833.8
Memantine717.217.3
Memantine Hydrochloride717.217.3
Suvorexant615.615.6
Droxidopa57.87.8
Pimavanserin Tartrate84.94.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.